Nalaganje...

MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ*

Tamoxifen represents a major adjuvant therapy to those patients with estrogen receptor-alpha positive breast cancer. However, tamoxifen resistance occurs quite often, either de novo or acquired during treatment. To investigate the role of miR-320a in the development of resistance to tamoxifen, we es...

Popoln opis

Shranjeno v:

Bibliografske podrobnosti
izdano v:	Sci Rep
Main Authors:	Lü, Mingrong, Ding, Keshuo, Zhang, Guofeng, Yin, Mianmian, Yao, Guidong, Tian, Hui, Lian, Jie, Liu, Lin, Liang, Meng, Zhu, Tao, Sun, Fei
Format:	Artigo
Jezik:	Inglês
Izdano:	Nature Publishing Group 2015
Teme:	Article
Online dostop:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4348640/ https://ncbi.nlm.nih.gov/pubmed/25736597 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep08735
Oznake:	Označite Brez oznak, prvi označite!

MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ*

Podobne knjige/članki